Literature DB >> 13679293

Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings.

R Nuri Sener1.   

Abstract

We herein report the case of a 15-year-old male patient with pantothenate kinase-associated neurodegeneration. The classic "eye-of-the-tiger" appearance was initially present on the globus pallidi on T2-weighted MR images and had disappeared by the time of the 10-month follow-up examination. Fluid-attenuated inversion recovery images revealed marked hypointensity in the globus pallidi and dentate nuclei and high signal intensity changes in the deep cerebral white matter. Proton MR spectroscopy revealed markedly decreased N-acetylaspartate in the globus pallidi, associated with decreased N-acetylaspartate and increased myoinositol in the deep cerebral white matter. Diffusion MR images (b=1000 s/mm(2)) were negative (normal appearing) for deep cerebral white matter lesions, whereas apparent diffusion coefficient values were slightly increased (1.08-1.12 x 10(-3) mm(2)/s), compared with the apparent diffusion coefficient values from the normal white matter regions. Apparent diffusion coefficient values in the globus pallidi were lower than those in the unaffected thalamus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679293      PMCID: PMC7973979     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

1.  Proton NMR chemical shifts and coupling constants for brain metabolites.

Authors:  V Govindaraju; K Young; A A Maudsley
Journal:  NMR Biomed       Date:  2000-05       Impact factor: 4.044

2.  Four siblings with Hallervorden-Spatz disease.

Authors:  U Vaher; A Napa; A Nurmiste; A Piirsoo; H Sibul; T Talvik
Journal:  Brain Dev       Date:  2001-07       Impact factor: 1.961

3.  Echo-planar and gradient-echo diffusion MRI of normal brain iron in the globus pallidus.

Authors:  R N Sener
Journal:  Clin Imaging       Date:  2002 Nov-Dec       Impact factor: 1.605

4.  Hallervorden-Spatz disease: late infantile type.

Authors:  P D Singhi; S Mitra
Journal:  J Child Neurol       Date:  1997-06       Impact factor: 1.987

5.  How broad is the phenotype of Hallervorden-Spatz disease?

Authors:  S J Hickman; N S Ward; R A Surtees; J M Stevens; S F Farmer
Journal:  Acta Neurol Scand       Date:  2001-03       Impact factor: 3.209

6.  Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome.

Authors:  S J Hayflick; J M Penzien; W Michl; U M Sharif; N P Rosman; P G Wheeler
Journal:  Pediatr Neurol       Date:  2001-08       Impact factor: 3.372

7.  Hallervorden-Spatz disease: MR and pathologic findings.

Authors:  M Savoiardo; W C Halliday; N Nardocci; L Strada; L D'Incerti; L Angelini; V Rumi; J D Tesoro-Tess
Journal:  AJNR Am J Neuroradiol       Date:  1993 Jan-Feb       Impact factor: 3.825

8.  Hallervorden-Spatz syndrome in two siblings diagnosed by clinical features and magnetic resonance imaging.

Authors:  S Tiamkao; B Nitinavakarn; S Jitpimolmard
Journal:  J Med Assoc Thai       Date:  2000-12

Review 9.  Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome).

Authors:  Neil Gordon
Journal:  Eur J Paediatr Neurol       Date:  2002       Impact factor: 3.140

10.  Late adult onset chorea with typical pathology of Hallervorden-Spatz syndrome.

Authors:  D A Grimes; A E Lang; C Bergeron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

View more
  7 in total

Review 1.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

2.  Pantothenate kinase-associated neurodegeneration with increased lentiform nuclei cerebral blood flow.

Authors:  M Koyama; A Yagishita
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

Review 3.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

4.  MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients.

Authors:  Milan Hájek; Miriam Adamovicová; Vít Herynek; Antonín Skoch; Filip Jírů; Anna Krepelová; Monika Dezortová
Journal:  Eur Radiol       Date:  2004-11-24       Impact factor: 5.315

5.  Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome).

Authors:  Robert A Egan; Richard G Weleber; Penelope Hogarth; Allison Gregory; Jason Coryell; Shawn K Westaway; Jane Gitschier; Soma Das; Susan J Hayflick
Journal:  Am J Ophthalmol       Date:  2005-08       Impact factor: 5.258

6.  Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration.

Authors:  Umesh C Parashari; Pallavi Aga; Anit Parihar; Ragini Singh; Vindhya Joshi
Journal:  Indian J Radiol Imaging       Date:  2010-08

7.  Proton magnetic resonance spectroscopy detects cerebral metabolic derangement in a mouse model of brain coenzyme a deficiency.

Authors:  Yanan Li; Jeffrey Steinberg; Zane Coleman; Shubo Wang; Chitra Subramanian; Yimei Li; Zoltan Patay; Walter Akers; Charles O Rock; Suzanne Jackowski; Puneet Bagga
Journal:  J Transl Med       Date:  2022-02-23       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.